Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC
Recalled May 7, 2025 · FDA recall D-0391-2025 · Preferred Pharmaceuticals
Hazard
cGMP Deviations · FDA Class II
Units
1190 Bottles
Sold at
Nationwide in the US
Description
cGMP Deviations
Product
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Manufacturer(s)
Preferred Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →